Search research articles
Contact Us
Filters
Showing results (151-160 of 172) with videos related to
Page
of 18
Sort By:
The Journal of Infectious Diseases
|
July 31, 2021
Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System Beneficiaries
Nusrat J Epsi, Stephanie A Richard, Eric D Laing, et al.
Plos One
|
October 17, 2022
Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection
Martha Sedegah, Chad Porter, Emilie Goguet, et al.
Frontiers in Immunology
|
June 28, 2021
Antibody Responses to SARS-CoV-2 Following an Outbreak Among Marine Recruits With Asymptomatic or Mild Infection
Irene Ramos, Carl Goforth, Alessandra Soares-Schanoski, et al.
The Journal of Animal Ecology
|
February 2, 2026
Cohorts of immature Pteropus bats show interannual variation in Hendra virus serology
Daniel E Crowley, Caylee A Falvo, Chris K Grant, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 17, 2021
Antigen-based multiplex strategies to discriminate SARS-CoV-2 natural and vaccine induced immunity from seasonal human coronavirus humoral responses
Eric D Laing, Spencer L Sterling, Stephanie A Richard, et al.
Open Forum Infectious Diseases
|
February 10, 2022
Anatomical Site, Viral Ribonucleic Acid Abundance, and Time of Sampling Correlate With Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 During Infection
F Julian Lantry, Nusrat J Epsi, Simon D Pollett, et al.
Frontiers in Immunology
|
September 15, 2023
Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durability
Elizabeth K Graydon, Tonia L Conner, Kim Dunham, et al.
Science Translational Medicine
|
April 5, 2022
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodies
Sabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
Biorxiv : the Preprint Server for Biology
|
January 4, 2022
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster
Sabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 7, 2021
Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers
Siâ Ana A Coggins, Eric D Laing, Cara H Olsen, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 172) with videos related to
Sort By:
Page
of 18
The Journal of Infectious Diseases
|
July 31, 2021
Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System Beneficiaries
Nusrat J Epsi, Stephanie A Richard, Eric D Laing, et al.
Plos One
|
October 17, 2022
Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection
Martha Sedegah, Chad Porter, Emilie Goguet, et al.
Frontiers in Immunology
|
June 28, 2021
Antibody Responses to SARS-CoV-2 Following an Outbreak Among Marine Recruits With Asymptomatic or Mild Infection
Irene Ramos, Carl Goforth, Alessandra Soares-Schanoski, et al.
The Journal of Animal Ecology
|
February 2, 2026
Cohorts of immature Pteropus bats show interannual variation in Hendra virus serology
Daniel E Crowley, Caylee A Falvo, Chris K Grant, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 17, 2021
Antigen-based multiplex strategies to discriminate SARS-CoV-2 natural and vaccine induced immunity from seasonal human coronavirus humoral responses
Eric D Laing, Spencer L Sterling, Stephanie A Richard, et al.
Open Forum Infectious Diseases
|
February 10, 2022
Anatomical Site, Viral Ribonucleic Acid Abundance, and Time of Sampling Correlate With Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 During Infection
F Julian Lantry, Nusrat J Epsi, Simon D Pollett, et al.
Frontiers in Immunology
|
September 15, 2023
Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durability
Elizabeth K Graydon, Tonia L Conner, Kim Dunham, et al.
Science Translational Medicine
|
April 5, 2022
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodies
Sabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
Biorxiv : the Preprint Server for Biology
|
January 4, 2022
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster
Sabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 7, 2021
Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers
Siâ Ana A Coggins, Eric D Laing, Cara H Olsen, et al.
Page
of 18